Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects
Clinical trial NCT02807116 · COMPLETED
Trial details
- NCT number
- NCT02807116
- Sponsor
- CTI BioPharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-02-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.